Uni-Bio Science Group Limited (0690.HK)
HKD 0.08
(10.29%)
HKD 0.08
(10.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 67.76 Million HKD | 32.45% |
| 2022 | 46.6 Million HKD | 370.91% |
| 2021 | -17.2 Million HKD | 50.33% |
| 2020 | -34.63 Million HKD | -191.35% |
| 2019 | -11.88 Million HKD | 89.98% |
| 2018 | -118.6 Million HKD | -60.68% |
| 2017 | -73.81 Million HKD | -38.36% |
| 2016 | -53.35 Million HKD | 11.83% |
| 2015 | -60.5 Million HKD | 4.26% |
| 2014 | -63.2 Million HKD | 7.94% |
| 2013 | -68.65 Million HKD | -13.66% |
| 2012 | -60.4 Million HKD | 17.33% |
| 2011 | -73.06 Million HKD | -2.95% |
| 2010 | -70.96 Million HKD | 60.07% |
| 2009 | -177.72 Million HKD | -63.11% |
| 2008 | -108.96 Million HKD | -132.41% |
| 2007 | 336.15 Million HKD | 167.78% |
| 2006 | 125.53 Million HKD | 392.33% |
| 2005 | -42.94 Million HKD | -934.49% |
| 2004 | 5.14 Million HKD | 159.93% |
| 2003 | -8.58 Million HKD | -1444.24% |
| 2002 | -556 Thousand HKD | -101.65% |
| 2001 | 33.64 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 35.9 Million HKD | 0.0% |
| 2024 Q1 | 35.9 Million HKD | 15.04% |
| 2023 FY | 61.73 Million HKD | 32.45% |
| 2023 Q1 | 21.91 Million HKD | -24.07% |
| 2023 Q2 | 37.38 Million HKD | 70.6% |
| 2023 Q3 | 18.53 Million HKD | -50.43% |
| 2023 Q4 | 31.2 Million HKD | 68.42% |
| 2022 Q4 | 28.85 Million HKD | 96.37% |
| 2022 Q1 | 8.92 Million HKD | 172.99% |
| 2022 Q2 | 11.39 Million HKD | 27.68% |
| 2022 Q3 | 14.69 Million HKD | 28.94% |
| 2022 FY | 46.6 Million HKD | 370.91% |
| 2021 Q4 | -12.22 Million HKD | -205.85% |
| 2021 Q1 | 1.58 Million HKD | 104.4% |
| 2021 Q2 | 2.23 Million HKD | 41.26% |
| 2021 Q3 | -3.99 Million HKD | -278.96% |
| 2021 FY | -17.2 Million HKD | 50.33% |
| 2020 Q2 | -15.93 Million HKD | -195.6% |
| 2020 FY | -34.63 Million HKD | -191.35% |
| 2020 Q4 | -35.93 Million HKD | -174.64% |
| 2020 Q3 | -13.08 Million HKD | 17.9% |
| 2020 Q1 | -5.39 Million HKD | 85.49% |
| 2019 Q3 | -36.54 Million HKD | 11.12% |
| 2019 Q2 | -41.11 Million HKD | -678.88% |
| 2019 Q1 | 7.1 Million HKD | 122.66% |
| 2019 FY | -11.88 Million HKD | 89.98% |
| 2019 Q4 | -37.14 Million HKD | -1.65% |
| 2018 FY | -118.6 Million HKD | -60.68% |
| 2018 Q1 | -31.61 Million HKD | -30.21% |
| 2018 Q3 | -31.34 Million HKD | 0.85% |
| 2018 Q2 | -31.61 Million HKD | 0.0% |
| 2018 Q4 | -31.34 Million HKD | 0.0% |
| 2017 Q2 | -16.66 Million HKD | 0.0% |
| 2017 Q1 | -16.66 Million HKD | 4.74% |
| 2017 FY | -73.81 Million HKD | -38.36% |
| 2017 Q4 | -24.27 Million HKD | 0.0% |
| 2017 Q3 | -24.27 Million HKD | -45.65% |
| 2016 Q4 | -17.49 Million HKD | 0.0% |
| 2016 Q1 | -11.98 Million HKD | -2.34% |
| 2016 FY | -53.35 Million HKD | 11.83% |
| 2016 Q3 | -17.49 Million HKD | -45.97% |
| 2016 Q2 | -11.98 Million HKD | 0.0% |
| 2015 Q3 | -11.71 Million HKD | 13.28% |
| 2015 Q4 | -11.71 Million HKD | 0.0% |
| 2015 FY | -60.5 Million HKD | 4.26% |
| 2015 Q1 | -13.5 Million HKD | 0.0% |
| 2015 Q2 | -13.5 Million HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 FY | -63.2 Million HKD | 7.94% |
| 2014 Q1 | -47.91 Million HKD | 0.0% |
| 2013 FY | -68.65 Million HKD | -13.66% |
| 2013 Q4 | -47.91 Million HKD | -553.29% |
| 2013 Q3 | -7.33 Million HKD | 0.0% |
| 2013 Q2 | -7.33 Million HKD | 70.23% |
| 2013 Q1 | -24.63 Million HKD | 0.0% |
| 2012 Q1 | -24.18 Million HKD | 0.0% |
| 2012 FY | -60.4 Million HKD | 17.33% |
| 2012 Q4 | -24.63 Million HKD | -282.13% |
| 2012 Q3 | -6.44 Million HKD | 0.0% |
| 2012 Q2 | -6.44 Million HKD | 73.34% |
| 2011 FY | -73.06 Million HKD | -2.95% |
| 2011 Q4 | -24.18 Million HKD | 0.0% |
| 2010 FY | -70.96 Million HKD | 60.07% |
| 2009 FY | -177.72 Million HKD | -63.11% |
| 2008 FY | -108.96 Million HKD | -132.41% |
| 2007 FY | 336.15 Million HKD | 167.78% |
| 2006 FY | 125.53 Million HKD | 392.33% |
| 2005 FY | -42.94 Million HKD | -934.49% |
| 2004 FY | 5.14 Million HKD | 159.93% |
| 2003 FY | -8.58 Million HKD | -1444.24% |
| 2002 FY | -556 Thousand HKD | -101.65% |
| 2001 FY | 33.64 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 92.453% |